Extending cancer drug patent for cutting the cost

As per the leading international authority on the disease, the involved cost of revolutionary and immensely expensive new cancer drugs could be reduced by governments by lengthening the involved patents. Dr Vishva Dixit stated on a visit to Dublin, that the cost of potentially lifesaving treatments should not be an obstruction to access.[more]